药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Spectinomycin
Dronedarone
The metabolism of Dronedarone can be decreased when combined with Midomafetamine.
Spectinomycin
Cyclobenzaprine
The risk or severity of CNS depression can be increased when Midomafetamine is combined with Cyclobenzaprine.
Spectinomycin
Testosterone undecanoate
Testosterone undecanoate may increase the hypertensive activities of Midomafetamine.
Spectinomycin
Solriamfetol
The risk or severity of hypertension can be increased when Solriamfetol is combined with Midomafetamine.
Spectinomycin
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Midomafetamine.
Spectinomycin
Thyrotropin
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Thyrotropin.
Spectinomycin
Benzylthiouracil
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Benzylthiouracil.
Spectinomycin
Elcatonin
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Elcatonin.
Spectinomycin
Methylthiouracil
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Methylthiouracil.
Spectinomycin
3,5-diiodothyropropionic acid
The risk or severity of adverse effects can be increased when Midomafetamine is combined with 3,5-diiodothyropropionic acid.
Spectinomycin
Protirelin
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Protirelin.
Spectinomycin
Potassium perchlorate
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Potassium perchlorate.
Spectinomycin
Thyroid, porcine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Thyroid, porcine.
Spectinomycin
Dibromotyrosine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Dibromotyrosine.
Spectinomycin
Potassium Iodide
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Potassium Iodide.
Spectinomycin
Teriparatide
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Teriparatide.
Spectinomycin
Parathyroid hormone
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Parathyroid hormone.
Spectinomycin
Abaloparatide
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Abaloparatide.
Spectinomycin
Tiratricol
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Tiratricol.
Spectinomycin
3,5-Diiodotyrosine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with 3,5-Diiodotyrosine.